The effectiveness of an oral gonadotropin-releasing hormone antagonist relugolix for retained products of conception (RPOC) formed after abortion at less than 22 weeks of gestation... by Satoko Sasatsu, Yosuke Ono, Dai Miyashita, Tatsuya Yoshihara, Kota Tanaka, So Owada, Kana Makino, Akiko Nakagomi, Maki Ogi, Eriko Ogasawara, Hikaru Tagaya, Hiroko Fukasawa, Yasuhiko Okuda, Osamu Yoshino

Get full text